Jakob Loven Biography and Net Worth

Director of Kronos Bio


Mr. Jakob Loven is the Director of Kronos Bio.

How do I contact Jakob Loven?

The corporate mailing address for Mr. Loven and other Kronos Bio executives is , , . Kronos Bio can also be reached via phone at 650-781-5200 and via email at [email protected]. Learn More on Jakob Loven's contact information.

Has Jakob Loven been buying or selling shares of Kronos Bio?

Jakob Loven has not been actively trading shares of Kronos Bio within the last three months. Most recently, Jakob Loven sold 14,004 shares of the business's stock in a transaction on Monday, April 19th. The shares were sold at an average price of $20.59, for a transaction totalling $288,342.36. Learn More on Jakob Loven's trading history.

Who are Kronos Bio's active insiders?

Kronos Bio's insider roster includes Norbert Bischofberger (CEO), Marianne De Backer (Director), Jorge DiMartino (VP), Christopher Dinsmore (Insider), and Jakob Loven (Director). Learn More on Kronos Bio's active insiders.

Are insiders buying or selling shares of Kronos Bio?

During the last year, Kronos Bio insiders bought shares 2 times. They purchased a total of 1,468,623 shares worth more than $1,202,320.20. During the last year, insiders at the sold shares 9 times. They sold a total of 91,887 shares worth more than $126,186.03. The most recent insider tranaction occured on February, 21st when SVP Elizabeth A Olek sold 7,368 shares worth more than $7,736.40. Insiders at Kronos Bio own 23.4% of the company. Learn More about insider trades at Kronos Bio.

Information on this page was last updated on 2/21/2024.

Jakob Loven Insider Trading History at Kronos Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/19/2021Sell14,004$20.59$288,342.36View SEC Filing Icon  
4/16/2021Sell33,162$21.01$696,733.62View SEC Filing Icon  
4/14/2021Sell32,636$22.80$744,100.80View SEC Filing Icon  
4/12/2021Sell15,828$26.28$415,959.84View SEC Filing Icon  
4/8/2021Sell63,128$27.41$1,730,338.48View SEC Filing Icon  
See Full Table

Jakob Loven Buying and Selling Activity at Kronos Bio

This chart shows Jakob Loven's buying and selling at Kronos Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Kronos Bio Company Overview

Kronos Bio logo
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and other serious diseases in the United States. The company's lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 2 clinical trial; and KB-9558, a core oncogenic transcription factor that drives multiple myeloma. Kronos Bio, Inc. was incorporated in 2017 and is headquartered in San Mateo, California.
Read More

Today's Range

Now: $1.30
Low: $1.22
High: $1.35

50 Day Range

MA: $1.13
Low: $1.02
High: $1.29

2 Week Range

Now: $1.30
Low: $0.73
High: $2.29

Volume

309,231 shs

Average Volume

256,344 shs

Market Capitalization

$78.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77